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arterial Digital Subtraction Angiography for Treatment Planning in
Patients with Peripheral Arterial Disease: A Randomised Controlled
Diagnostic Trial
Vahl A.C., Geselschap J., Montauban van Swijndregt A.D., Smit J., Sala J.,
Turkcan K., Dijksman L.M, Visser M.J.T. Eur J Vasc Endovasc Surg
2008;35:514-21.
Objectives: To compare the diagnostic and therapeutic confidence,
patient outcome and costs between MRA and DSA as the initial diagnostic
imaging test, in patients with symptomatic arterial disease of the leg.
Design: Randomised controlled diagnostic trial.
Materials and methods: Patients were randomly allocated to MRA
(n  97) or DSA (n  100). Primary outcomes were: ability to make
treatment plan and patients satisfaction. Secondary endpoints were: type of
treatment and costs.
Results: A treatment plan was determined for each included patient.
Additional imaging was necessary in 11% of patients in the MRA group
compared to 10% in the DSA group (p  0.5). 84% of the patients who
received MRA judged the diagnostic work up as comfortable compared to
57% who had DSA (p  0.013). Within 4 months of randomization 30
patients in the MRA group compared to 34 patients in de DSA group
underwent operative procedures; 39 versus 36 patients respectively under-
went angioplasty. The mean total in-hospital costs during the first 4 months
were €4768,- in the MRA group compared to €4697,- in the DSA group
(95% CI of difference 1331;1472).
Conclusions: In patients with peripheral arterial disease of the leg
an adequate treatment plan can be made with MRA. This diagnostic
strategy was experienced as more comfortable and less painful compared
to DSA. Total diagnostic and treatment costs of both strategies were
comparable.
Prevalence of Micro-Emboli in Symptomatic High Grade Carotid
Artery Disease: A Transcranial Doppler Study
Zuromskis T., Wetterholm R., Lindqvist J. Fredén, Svedlund S., Sixt C.,
Jatuzis D., Obelieniene D., Caidahl K., Volkmann R. Eur J Vasc Endovasc
Surg 2008;35:534-40.
Background and purpose: Echolucent carotid plaques, as well as
downstreammicro-embolisation, may be associated with an increased risk of
stroke. However, the relationship between carotid plaque ultrasound char-
acteristics and micro-embolic signals (MES) detected in the middle cerebral
artery (MCA) is still controversial. The purpose of this study was to investi-
gate the prevalence ofMES in patients with symptomatic high-grade internal
carotid artery (ICA) stenosis and to identify predisposing factors, such as
plaque echogenicity and intra stenotic blood flow velocity pattern.
Methods: 197 patients (mean age 69.5  8.6, 161 males) with con-
firmed symptomatic high-grade ICA stenosis and anti-platelet treatment
underwent bilateral MES monitoring for 30 minutes within the anterior
circulation, using Power M-mode transcranial Doppler techniques (TCD).
Carotid artery plaques were characterized by Gray-Weale scaling.
Results: In 32.0% of the patients, we detectedMES by TCDwithin the
MCA on the symptomatic side, but the same finding was made in only 4.5%
on the corresponding asymptomatic site (p  0.0001). The presence or
absence of MES was associated with neither ultrasonic plaque characteristics
nor the intrastenotic blood flow velocities at peak systole and end diastole.
The median time since the last ischemic event symptoms was shorter in the
patient group with MES [] than in MES [] (p  0.013).
Conclusions: Despite optimum standard anti-platelet therapy, cere-
bral micro-embolisation occurs in 30% of patients with symptomatic carotid
artery disease, which might therefore be a possible risk factor for recurrent
neurological symptoms. However, the presence of MES is independent of
intrastenotic blood flow disturbances and grey scale ultrasound plaque
characteristics. The presence of MES as an indicator of unstable plaque and
thereby a possible risk factor for stroke should be evaluated prospectively
using various algorithms for plaque classifications.
Experienced Endovascular Interventionalists Objectively Improve their
Skills by Attending Carotid Artery Stent Training Courses
Van Herzeele I., Aggarwal R., Neequaye S., Hamady M., Cleveland T.,
Darzi A., Cheshire N., Gaines P. Eur J Vasc Endovasc Surg 2008;35:541-50.Objective: Carotid artery stenting (CAS) is an advanced endovascular
intervention with a steep learning curve. Virtual reality (VR) simulation has
been proposed as a means to train and objectively assess technical perfor-
mance.
Aim: To objectively assess psychomotor skills acquisition of experi-
enced interventionalists attending a two-day CAS course, using a VR simu-
lator.
Methods: Both cognitive and technical skills of 11 interventionalists
were trained in a two-day course using didactic sessions, case reviews,
supervised VR simulation and live-cases. Pre- and post-course skills were
assessed through performance on the same CAS procedure using metrics
derived from the simulator.
Results: Significant differences were noted between pre- and post-
course performance for procedure (36 vs. 20 min., p  0.005), X-ray (20 vs.
11 min., p  0.016) and delivery-retrieval time of the embolic protection
device (12 vs. 9 min., p  0.007). Advancement of the guiding catheter
without a leading wire occurred to a greater extent pre- versus post-course
(199 vs. 152 mm., p  0.050) as did spasm of the internal carotid artery (4
vs. 2, p  0.049).
Conclusions: This study has objectively proven a benefit for experi-
enced interventionalists to attend CAS courses for skills acquisition mea-
sured by a VR simulator. These data can be used to offer participants an
insight into their skills and objectively audit course efficacy.
Meta Analysis on Mortality of Ruptured Abdominal Aortic Aneurysms
Hoornweg L.L., Storm-Versloot M.N., Ubbink D.T., Koelemay M.J.W.,
Legemate D.A., Balm R. Eur J Vasc Endovasc Surg 2008;35:558-70.
Objectives: To assess the mortality of patients with ruptured abdomi-
nal aortic aneurysms undergoing open surgery and examine changes in
mortality over time.
Methods: Literature databases were searched for relevant articles pub-
lished between 1991 and 2006. Two reviewers independently performed
study inclusion and data extraction. Primary outcomemeasure was 30 day or
in-hospital mortality. Subgroup analyses were performed examining the
effect of population- and hospital-based studies, hospital volume and type of
surgeon.
Results: From a total of 1419 identified studies, 145 observational
studies met the inclusion criteria of which 116 were included in the system-
atic review comprising 60,822 patients. Overall mortality was 48.5% (95%
CI: 48.1–48.9%) and did not change significantly over the years. Age
increased over the years. For overall mortality a trend was seen in favour of
high-volume hospitals.
Conclusions: This meta-analysis suggests that mortality of patients with
RAAA treated by open surgery has not changed over the past 15 years. This
could be explained by increased age of patients undergoing RAAA repair.
A Model to Predict Outcomes for Endovascular Aneurysm Repair
Using Preoperative Variables
Barnes M., Boult M., Maddern G., Fitridge R. Eur J Vasc Endovasc Surg
2008;35:571-79.
Purpose: Models have been developed to predict the likely outcomes
of endovascular aneurysm repair (EVAR) for patients, based on a longitudi-
nal Australian audit.
Methodology: Mid-term progress of 961 Australian patients who
underwent EVAR has been collected and used to develop predictive models
for 17 outcomes.
Stepwise forward logistic regressions determined the significant preop-
erative patient variables to be included in each outcome model. An interac-
tive program was subsequently developed to allow surgeons to review the
predicted success rates for patients about to undergo the procedure. Each
model was assessed using a global goodness of fit test and was internally
validated using bootstrapping.
Results: Eight pre-operative variables were included in the interactive
model for 17 outcomes. The eight variables usedwere aneurysm size, age, ASA,
gender, creatinine, aortic neck angle, infrarenal neck diameter and infrarenal
neck length. The outcomes predicted included perioperative mortality, periop-
erative morbidity, mid-term survival and reintervention rates.
All outcome models achieved reasonable goodness of fit, with the
exception of the model for conversion to open repair (p  0.04). With
respect to validation, survival, aneurysm related deaths, migrations, ruptures
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discrimination. Models for survival, migrations and conversions to open
repairs performed best in terms of bias corrected R-squared index. The
models with the smallest calibration error were 3 and 5 year survival, early
deaths and mid-term type I endoleaks.
Conclusions: An interactive model is available, which can assist vascu-
lar surgeons to evaluate the expected outcomes for a particular patient
undergoing EVAR. The validated model is useful for counselling and
pre-operative decision making.
Elevated Plasma MMP1 and MMP9 are Associated with Abdominal
Aortic Aneurysm Rupture
Wilson W.R.W., Anderton M., Choke E.C., Dawson J., Loftus I.M.,
Thompson M.M. Eur J Vasc Endovasc Surg 2008;35:580-84.
Background: The role of matrix metalloproteinases (MMPs) in
abdominal aortic aneurysm (AAA) formation is well established. How-
ever the changes in plasma MMP levels with AAA rupture have not been
reported. The aim of this study was to determine circulating levels of
MMPs in non-ruptured and ruptured AAA immediately prior to open
repair.
Methods: Concentrations of MMPs and their endogenous tissue in-
hibitors (TIMPs) were quantified using ELISA in pre-operative plasma
samples from non-ruptured and ruptured AAA.
Results: MMP1 and MMP9 were elevated in the plasma of ruptured
AAA versus non-ruptured AAA. A four-fold elevation in pre-operative
plasma MMP9 was associated with non-survival at 30 days from rupture
surgery compared with those surviving for greater than 30 days.
Conclusion: In conclusion, these findings support the role ofMMPs in
AAA pathogenesis. Elevation of MMP9 was associated with ruptured aneu-
rysm related 30-day mortality and may represent a survival indicator in this
group.
Need for Late Lower Limb Revascularization and Major Amputation
after Coronary Artery Bypass Surgery
Biancari F., Kangasniemi O.-P., Mahar M.A.A., Ylönen K. Eur J Vasc
Endovasc Surg 2008;35:596-602.
Objectives: The aim of the present study was to estimate the need for
late lower limb revascularization and/or major amputation after coronary
artery bypass grafting (CABG).
Design: Retrospective study.
Patients andmethods: 1307 residents of Oulu who underwent CABG
from 1990 to 2006 formed the basis of this community-wide study.Readers can access EJVES articles at http://intl.emajor amputations. In four patients, revascularization was done for compli-
cated wound after vein graft harvesting. Freedom rates from lower limb
revascularization and/or major amputation at 5-, 10- and 15-year were
92.9%, 88.4% and 85.1%, whereas freedom rates from lower limb revascu-
larization for critical ischemia and/or major amputation were 98.1%, 95.2%
and 94.7%. Age (p  0.013, HR 1.05), extracardiac arteriopathy
(p  0.0001, HR 5.39), left ventricular ejection fraction classes (p  0.03),
diabetes (p  0.0001, HR 5.78), and estimated glomerular filtration
rate 60 mg/min/m2 (p  0.02, HR 2.22) were independent predictors
of lower limb revascularization for critical leg ischemia and/or major ampu-
tation.
Conclusions: Patients with extracardiac arteriopathy, diabetes and
decreased glomerular filtration rate at the time of CABG are at risk for late
lower limb ischemia. These patients would most benefit of a closer follow-up
for prevention of peripheral vascular disease and its related complications.
Effect of Operating Surgeon on Outcome of Arteriovenous Fistula
Formation
Gundevia Z., Whalley H., Ferring M., Claridge M., Smith S., Wilmink T.
Eur J Vasc Endovasc Surg 2008;35:614-18.
Objective: To study whether surgical trainees can perform arterio-
venous fistula (AVF) surgery to a standard comparable to consultants.
Patients and methods: Retrospective study of all vascular access
surgery over a three year period at a single centre. The operating surgeon was
identified from theatre log books and categorised by grade. Fistula patency
was used as the primary outcome measure and was determined from pa-
tients’ case-notes and from a prospectively collected electronic record of
dialysis sessions. Patency was defined as “used for dialysis” if the AVF was
used for dialysis for at least 6 consecutive sessions.
Results:One hundred and eighty six cases were used for analysis. In
60 cases (32%) the operating surgeon was the consultant, in 53 cases
(29%) a trainee was supervised by a consultant, in 56 cases (30%) a trainee
performed the operation independently and in 17 cases (9%) the grade of
the operating surgeon could not be established. Primary and primary
assisted patency rates by operating surgeon did not differ significantly
(P-values 0.25 and 0.16 respectively). Age of the patient was the only
predictor of patency failure in a multivariate model. Grade of operating
surgeon (logrank test 2  3.1, p  0.38) and type of fistula (logrank
test 2  2.3, p  0.52) were not significantly related to the primary
survival of the fistula.
Conclusions: This study showed no significant differences in AVF
patency rates between trainee and consultant surgeons. Allocation of
appropriate cases can result in trainees obtaining similar outcomes as
consultants, demonstrating that dialysis access surgery can provide goodResults: During a mean follow-up of 7.1  4.5 years, 111 patients
(8.5%) underwent 251 vascular procedures for lower limb ischemia and 25
training opportunities for junior doctors without detriment to patient
care.lsevierhealth.com/journals/ejvs/default.cfm
